Viltolarsen (Viltepso) clinical policy
Governs medical necessity and coverage guidance for viltolarsen (Viltepso) therapy as adopted by the Health Plan; affects providers and members covered by the Health Plan, including Medicaid when state rules apply.
No material clinical or coverage changes in this revision.
Coverage Criteria
Coverage under this clinical policy is subject to the member’s contract and the plan’s governing documents. Specifically, coverage decisions and the administration of benefits are subject to all terms, conditions, exclusions, and limitations of the member’s coverage documents (for example, evidence of coverage, certificate of coverage, policy, or contract of insurance), and to applicable state and federal requirements and Health Plan-level administrative policies and procedures.
Provider Actions and Requirements
Prior authorization guided by medical necessity
This clinical policy is used to guide medical necessity determinations for prior authorization decisions. Prior authorization requirements are applied when the Health Plan’s utilization management processes indicate review is required to determine whether requested services meet medical necessity and coverage criteria.
Possible plan-level utilization management
The Health Plan may implement plan-level utilization management requirements — for example, changes to coverage, additional utilization controls (step therapy, quantity limits), or administrative amendments. Providers should verify member-specific plan terms and any plan-level utilization management before providing services.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.